Prognostic relevance of the histological subtype of renal cell carcinoma by DALL'OGLIO, Marcos F. et al.
3Prognostic Relevance of the Histological Subtype of RCC Clinical Urology
International Braz J Urol Vol. 34(1): 3-8, January - February, 2008
Prognostic Relevance of the Histological Subtype of Renal Cell
Carcinoma
Marcos F. Dall’Oglio, Alberto A. Antunes, Antonio C. Pompeo, Alcides Mosconi, Katia R. M.
Leite, Miguel Srougi
Division of Urology, School of Medicine, University of Sao Paulo, USP, Sao Paulo, SP, Brazil
ABSTRACT
Objective: According to several studies, when the histological subtype of renal cell carcinoma is established it is possible
to attribute a different life expectancy to each patient. We analyzed the prognostic significance of the histological subtype
in renal cell carcinoma.
Materials and Methods: The authors retrospectively analyzed the follow-up of 230 patients after radical or conservative
renal surgery. The histological characteristics of the different subtypes of tumor were obtained and the disease-free and
cancer-specific survival curves for the clear cell, cromophobic, papillary, collecting duct (Bellini) subtypes and those with
sarcomatoid differentiation were individualized.
Results: The disease-free and cancer-specific survival rates for clear cell tumors were 76.6% and 68.0% respectively, 71.2%
and 82.1% respectively for the cromophobic type, 71.1% and 79.8% respectively for the papillary type, 26.9% and 39.3%
respectively for the sarcomatoid type, and 0.0% and 0.0% respectively for the collecting ducts (p < 0.001).
Conclusion: The histological subtypes of renal tumors can stratify patients into different prognostic groups only when the
sarcomatoid differentiation is present.
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INTRODUCTION
The distinct histological subtypes of renal cell
carcinoma (RCC) have been widely studied as an in-
dependent prognostic factor. The histological classifi-
cation has recently been internationally standardized
and accepted (1). However, the aggressive behavior
of each biological pattern is still under discussion.
The most common RCC subtypes are: clear
cell (75%); papillary (15%); cromophobic (5%) and
collecting duct carcinoma (2%) (2). Sarcomatoid de-
generation may occur in any of the four RCC sub-
types (1) and increases the risk related to the aggres-
siveness of the disease.
Whether the histological types of RCC
present differences regarding the survival rate is still
a controversial issue (3-7). The aim of this study was
to evaluate the RCC behavior after surgical treatment
by histological subtype.
MATERIALS AND METHODS
Two hundred and thirty patients with RCC
who had undergone surgical treatment at our institu-
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tion between March/1991 and June/2003 were as-
sessed retrospectively. Their ages ranged from 44 to
80 years (median 63 years). The group evaluated was
homogeneous and the follow-up occurred between
three and two hundred months (median 48 months).
The surgeries performed were 168 radical nephrec-
tomies (73%), 44 enucleation (19%), and 18 polar
nephrectomies (8%).
The surgical specimen for pathological analy-
sis was fixed in formalin, soaked in paraffin, sectioned
and fixed in the usual way with eosin-hematoxylin
(EH). Classification by histological subtypes: (clear
cell, papillary cromophilic), cromophobic and collect-
ing duct was undertaken. Further, sarcomatoid differ-
entiation, characterized by the stretching of the tumor
cells, nuclear grade, pleomorphism, mitotic index and
tumor necrosis, was analyzed. Immunohistochemical
analysis was performed on eight patients with sarco-
matoid differentiation tumors only and confirmed the
presence of an epithelial component. The other seven
had sarcomatoid differentiation in association with
clear cell carcinoma.
All patients were evaluated according to age,
gender, symptoms upon presentation, disease stage,
pathologic characteristics, administration of adjuvant im-
munotherapy, time to disease recurrence, and survival.
The demographic data is showed in the Table-1.
The follow-up after surgery was based on
thorax X-ray, computerized tomography and/or ab-
dominal ultrasound and hematological tests each four
months during the first year, once per semester from
the second to fifth years and annually thereafter.
The survival curve analysis was carried out
by the Kaplan-Meier statistical method and the log
Rank test was used to compare data. Statistical sig-
nificance was considered as a p < 0.05.
RESULTS
Of the 230 tumors, there were 148 clear cell
tumors (64%), 46 cromophilic tumors (20%), 23
cromophobic tumors (10%), 15 sarcomatoid tumors
(5.6%) and 1 Bellini’s duct tumor (0.4%).
Regarding histological type, there was a 76.6%
disease-free survival rate for the clear cell type, 71.2%
for the cromophobic type, 71.1% for the papillary type,
26.9% for the sarcomatoid type, and 0.0% for the
Bellini duct type (Figure-1). The cancer-specific sur-
Table 1 – Demographic data.
N = 230
59 ± 12
(9.0 - 90.0)
168 (73.0%)
062 (27.0%)
120 (52%)
110 (48%)
180 (79.3%)
047 (20.7%)
169 (73.5%)
061 (26.5%)
212 (92.2%)
018 (7.8%)
148 (64.3%)
023 (10.0%)
045 (19.6%)
013 (5.7%)
001 (0.4%)
145 (63.3%)
084 (36.7%)
216 (93.9%)
014 (6.1%)
171 (74.3%)
059 (25.7%)
Patients
Age
Mean ± standard deviation
Gender
     Male
     Female
Clinical presentation
     Incidental
Symptomatic
Surgery
     Radical
     Nephron-sparing
Tumor Size
     ≤ 7 cm
     > 7 cm
Characteristics
     Single
     Multiple
Histologic type
     Clear cell
     Cromophobe
     Papillary
     Sarcomatoid
     Bellini’s cell
Grade
     1 or 2
     3 or 4
Lymph nodes
     Negative
     Positive
Microvascular invasion
     Negative
     Positive
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vival rate was 68.0% for the clear cell histological
type, 82.1% for the cromophobic, 79.8% for the pap-
illary, 0.0% for the sarcomatoid and the Bellini duct
(Figure-2).
For the sarcomatoid pattern, many tumors
were medium size 9.5 cm (4 to 24 cm), and 86.6%
were high-grade tumors and stage PT3-T4.
However, there was no statistical difference
as regards survival rates for the distinct histological
subtypes, except when there was an association with
the sarcomatoid pattern (Figures-1 and 2). The pres-
ence of only one patient with the Bellini duct subtype
with extremely aggressive behavior was insufficient
for more accurate evaluation. However, every time
the different histological types were compared with
the common type (clear cell) with the Cox regression
model for recurrence (Table-2), the risk was higher
only in this single case (Bellini duct) and with the sar-
comatoid tumors with a large confidence interval.
COMMENTS
Our study demonstrated that there was no
difference regarding tumor behavior among the RCC
histological subtypes, nor as regards survival rates
related to the clear cell, papillary and cromophobic
subtypes. The collecting duct subtype only occurred
in one patient and led to premature death. Sarcoma-
toid degeneration associated with the clear cell sub-
Figure 1 – Probability disease recurrence curve by histological type (p < 0.001).
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Table 2 - Cox regression model for recurrence.
Variable
Subtype
Papillary/ clear cell
Cromophobic/ clear cell
Sarcomatoid/ clear cell
Bellini/ clear cell
Relative Risk
01.176
01.154
04.475
16.802
CI (95%)
[0.497 ; 2.781]
[0.394 ; 3.381]
[1.889 ; 10.603]
[2.169 ; 130.175]
p Value
0.713
0.794
0.001
0.007
type occurred in half of the cases, and life expect-
ancy dropped in these cases from 71-75% to 39%
over five years.
It is believed that the cromophobic subtype
has a better prognosis than the conventional clear cell
subtype, and that the papillary subtype is of interme-
diate behavior (8). The renal cromophobic carcinoma
seems to have a better prognosis than the clear cell
subtype (9), however this is controversial since the
series are short, the tumors were low grade, were
Figure 2 – Probability curves of death due to the disease by histological type (p < 0.001).
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discovered in the initial stages, and presented behav-
ior similar to that of the clear cell subtype (10). The
cromophobic tumor was more indolent with a tendency
to remain organ confined even when it grows (11),
and affording a better survival rate than the clear cell
subtype (78% versus 50%) (12). Aggressive variants
of the cromophobic RCC have been described (13),
which justifies further investigation.
Our study showed that all histological sub-
types had similar behaviors. However, the survival time
was reduced when sarcomatoid degeneration oc-
curred. Another point to be emphasized is the clear
cell association with the sarcomatoid pattern in 45%
(7/15) of the cases. Among the cases of RCC, the
sarcomatoid differentiation occurs within a range of
2% to 5%, frequently associated with the conventional
clear cell carcinoma (14).
Usually, the papillary subtype is associated
with a better prognosis than the clear cell pattern (15).
Thus, the new classification divided it into type 1 (ba-
sophilic) and type 2 (eosinophilic), thus its behavior is
distinct, type 2 tumors being more aggressive, gener-
ally of high grade and at more advanced stages (12).
Solid papillary RCC variations identified only by cyto-
genetic analysis may be responsible for more aggres-
sive behavior (4).
The collecting duct tumors are highly aggres-
sive and develop systemic metastases rapidly (16). In
this study, only one patient that presented RCC at the
collecting ducts underwent nephrectomy and died six
months later. There is a consensus that the collecting
duct carcinoma (or Bellini’s) is very rare (< 1%) and
has a worse prognosis with the development of early
metastases (11, 16, 17) and death in 67% (11) of pa-
tients during the first two years. However, MacLennan
et al. (18) identified collecting duct tumors with lesser
aggression in RCC.
The metastatic potential of RCC shows that
the aggression seems to be greater in the clear cell
subtype (65%), decreases in the papillary (14%; in-
termediary risk), and is least in the cromophobic sub-
type (8%; lower risk) (19).
In our series we found no statistical signifi-
cant differences among the histological types regard-
ing the survival rate or recurrence, except as com-
pared to tumors with sarcomatoid degeneration (mean
survival: 5 years - 40%, 10 years - 0%). However,
Patard et al. (20) confirm the relative prognostic im-
portance of histological subtype as compared to grade
and stage. Our results may reflect the fact that pa-
tients in Brazil are presenting with larger (more than
a quarter had tumors > 7 cm) and more symptomatic
tumors (almost 50%) and survival differences are elimi-
nated across histological subtypes that when occurs.
CONCLUSION
The histological subtypes of renal tumors rep-
resent an ominous prognostic factor only when there
is associated sarcomatoid degeneration.
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